Perspectives for the pharmacological treatment of overactive bladder syndrome

It has been found that antimuscarinic drugs, viewed as the "gold standard" in overactive bladder syndrome (OAB) treatment, have an unsatisfactory tolerance profile and limited clinical effectiveness. This fact has given a clear impetus to search for new options in OAB pharmacotherapy. The conducted pre-clinical trials have led to the development of new solutions for the treatment of OAB, which stand a good chance of being applied in clinical practice. The said compounds are characterised by higher receptor and organ specificity than currently used medications.

Ginekologia polska. 2017 Jan [Epub]

Andrzej Wróbel, Tomasz Kluz, Grzegorz Surkont, Edyta Wlaźlak, Paweł Miotła, Katarzyna Skorupska, Tomasz Rechberger

Second Department of Gynecology, Medical University of Lublin,, Jaczewskiego 8, PL 20-090 Lublin, Poland, 20-090, Lublin, Poland. .